SEC Form 4 · accession 0001415889-18-000694
Medite Cancer Diagnostics, Inc. · MDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory Fortunoff
Director
Period of report
Feb 4, 2018
Accepted (ET)
May 8, 2018 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075439
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 4, 2018 | P | 1,333,334 | $0.75 | A | 1,533,334 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secured Convertible Note | $0.075 | Feb 4, 2018 | P | 100,000 | A | Aug 4, 2018 | Feb 4, 2020 | Common Stock | 1,333,334 | 100,000 | D |